Going forward..., page-1098

Hitting $1.70 for the first time ever and closing at an all time high of $1.68. Amazing!

That's when so called experts used to show up on this thread, sharing their "concerns" with us. Not this time it seems. This might be a sign that we are on our way to complete the transformation from a "hollow chocolate bunny" to a "force to be reckoned with".

Btw, as of 28/02/19, Fidelity owned 10.035% of shares issued (that's taking into account today's 50k option conversion already):



Hopefully events within the next few days will allow our CEO to sell the story even better in China at the end of this month:
http://www.ausbiotechinvestment.com.au/uploads/Australia%20China%20Biotech%20Invest%20Partnering%202019%20program%20and%20ACLSS%20program.pdf

Put a reminder in your calendar for the end of May:
Slukvin presenting in Melbourne on Wednesday 29th May ("Clinical Trials Part I: MSC Sources, Applications and ‘Off the Shelf’ Products (MSC Workshop)"),
Kelly on Thursday 30th May ("Think Big and Think Early to prevent Failure at Commercial Scale"),
Slukvin again on 31st May ("Production of iPSCs for Clinical Use (Plenary Satellite)"),
followed by a "Corporate Product Theatre Hosted By Cynata Therapeutics" also that Friday:
http://www.isct2019.com/program/